To determine whether rapamycin treatment promotes TGM2 expression in other cancer cell lines, we measured Tgm2 transcript levels in MCF-7 (PTEN-mutant breast cancer) and 786-O (PI3K-mutant renal cancer) cells. Here, TGM2 is linked to renal carcinoma.